Aesthetics

Del Pharmaceuticals is displaying its newest product, Dermarest Stretch Mark Repair Cream, at the 63rd Annual Meeting.

Allergan, Inc., has launched Prevage, antioxidant cream, the first and only clinically tested antioxidant that not only reduces the appearance of fine lines and wrinkles, but also provides protection against environmental factors including sun damage, air pollution and cigarette smoke, says the company.

Dermatologists should become environmental activists in their communities and on a broader scale, urges Peyton E. Weary, M.D.

Former AAD president, Rex A. Amonette, M.D., received the Gold Metal award, the highest award given by the Academy, yesterday.

Members of the American Academy of Dermatology and the AAD Association began voting online Sunday for 2006 officers and directors.

The Women's Dermatologic Society celebrated its thirtieth year in existence in an awards luncheon yesterday.

Clay J. Cockerell, M.D., assumes the post of AAD president tomorrow.

Neocutis, San Francisco, is introducing Bio-restorative Skin Cream with PSP. PSP is a proprietary cosmetic ingredient developed at the University of Lausanne, Switzerland. It is the only cosmeceutical product containing the specific natural human growth factors, cytokines and enzymatic antioxidants associated with natural bio-restoration of the skin to promote scarless wound healing. According to the company, the unique formulation of PSP provides skin with the optimal balance of skin nutrients helping to preserve or restore skin when stressed.

Neocutis, San Francisco, is introducing Bio-restorative Skin Cream with PSP. PSP is a proprietary cosmetic ingredient developed at the University of Lausanne, Switzerland. It is the only cosmeceutical product containing the specific natural human growth factors, cytokines and enzymatic antioxidants associated with natural bio-restoration of the skin to promote scarless wound healing. According to the company, the unique formulation of PSP provides skin with the optimal balance of skin nutrients helping to preserve or restore skin when stressed.

Valeant Pharmaceuticals is displaying two new products in its Kinerase line.

PharmaDerm is launching two new marketing campaigns toward dermatologists at the 63rd Annual Meeting.

WaveLight Laser Technolgie AG of Erlangen, Germany, is introducing three aesthetic lasers to the U.S. market at the 63rd Annual Meeting. Already used in Europe and Asia, the Sinon Q-switched ruby, the Mydon Nd:YAG and the Arion Alexandrite lasers will be Wavelight's first products to enter the U.S. market.

According to a research study presented yesterday, infliximab (Remicade) was found effective in treating psoriatic arthritis.

Botulinum toxin type A (Botox Cosmetic, Allergan) can be used safely and effectively in a range of doses to simultaneously treat a spectrum of upper facial rhytids in adult women, but a higher dose provides more marked and more durable efficacy without compromising safety, according to the results of a dose-comparison study presented by Alastair Carruthers, M.D., and Jean Carruthers, M.D.

Boni E. Elewski, M.D., president of the American Academy of Dermatology (AAD), will award the distinguished presidential citation to 20 members today.

Familiarity with popular beliefs about factors affecting acne is an integral part of managing patients.

Botulinum toxin treatments in the lower third of the face and the neck require caution.

While psychological stress impacts skin function, its effects on human skin physiology have not been well documented.

Psoriasis is a chronic skin disorder that affects approximately 2 percent of the U.S. and European population.

While psychological stress impacts skin function, its effects on human skin physiology have not been well documented.

As researchers learn more about botulinum toxin, clinicians continue to refine techniques for treating the upper face, especially in male patients.

Botulinum toxin treatments in the lower third of the face and the neck require caution.

Hand eczema is one of the most common work-related illnesses or diseases, but diagnosis is complicated.

With the hope of presenting practical advice that can be applied clinically to female patients by dermatologists, experts brought forward issues that consistently require attention, with the focus on one therapy that may forever change leg vein therapy.

Currently, off-label use of highly purified, medical grade 1000-centisoke silicone oil (Silikon 1000, Alcon Laboratories) as a permanent filler material seems to best fulfill the need for persistent, safe, cost-effective and natural-appearing correction.

SkinMedica, Carlsbad, Calif. is introducing three new products at the 63rd annual meeting.

Modern medical acupuncture can be used in conjunction with current Western treatments in dermatology to optimize patient outcome.

St. Louis, Mo. — According to a recent survey, hyperhidrosis afflicts nearly 3 percent of the U.S. population, with about half of sufferers experiencing axillary hyperhidrosis and many patients experiencing social, professional and other consequences that often go unaddressed.

National report — The impact of the Florida bogus Botox poisonings has been something of a tempest in a test tube for doctors contacted by Dermatology Times.

Rio de Janeiro, Brazil — Members of the Pigmentary Disorders Academy (PDA) convened here last November for their second annual meeting. While still in its infancy and relatively small in size, the group has already made significant progress as they pursue their mission to optimize care of patients affected by pigmentary disorders.